Literature DB >> 2558890

Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.

K Takagi1, T Kuzuya, T Horiuchi, M Nadai, R Apichartpichean, Y Ogura, T Hasegawa.   

Abstract

A possible pharmacokinetic interaction between theophylline and repirinast has been investigated in asthmatic patients. The kinetics of theophylline was studied in seven adult in-patients given theophylline 400-800 mg b.d. alone and after three weeks of co-administration of repirinast. There was no effect on the kinetics of the combined treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558890     DOI: 10.1007/BF00679789

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children.

Authors:  G Levy; R Koysooko
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  [Effect of azelastine on theophylline clearance in asthma patients].

Authors:  H Asamoto; M Kokura; A Kawakami; Y Sasaki; H Fujii; T Sawano; S Iso; T Ooishi; Y Horiuchi; N Ohara
Journal:  Arerugi       Date:  1988-10

3.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

5.  Evaluation of "toxic" serum theophylline concentrations.

Authors:  W S Burkle; C J Gwizdala
Journal:  Am J Hosp Pharm       Date:  1981-08

Review 6.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

7.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

8.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

9.  Inhibition of theophylline metabolism by long-term allopurinol administration.

Authors:  R L Manfredi; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

10.  Cimetidine decreases theophylline clearance.

Authors:  J E Jackson; J R Powell; M Wandell; J Bentley; R Dorr
Journal:  Am Rev Respir Dis       Date:  1981-06
View more
  4 in total

1.  Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose.

Authors:  D Beermann; H G Schaefer; M Wargenau; B Heibel; Y Sturm; J Kuhlmann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

3.  Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  T Hasegawa; K Takagi; T Kuzuya; M Nadai; R Apichartpichean; I Muraoka
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Kinetic interaction between theophylline and a newly developed anti-allergic drug, pemirolast potassium.

Authors:  T Hasegawa; K Takagi; M Nadai; Y Ogura; T Nabeshima
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.